More than three hundred King & Spalding lawyers across our litigation, transactional and regulatory teams devote all or a substantial portion of their practice to serving clients in every segment of the Life Sciences and Healthcare sectors. The comprehensive scope of the practice is unique: from helping to establish the start-ups developing the latest breakthrough drugs and medical devices, to defending the world’s largest pharmaceutical manufacturers in precedent-setting legal challenges, to representing major healthcare systems on their thorniest Medicare/Medicaid litigation or their strategic acquisitions, to counseling on the full spectrum of regulatory matters that these diverse entities face. We fully leverage our ability to draw on such broad expertise as we work together to achieve outcomes that best protect and advance the interests of our clients across these sectors.
The lawyers in this group bring exceptionally deep industry and technical knowledge, many with advanced degrees in life sciences and medical fields as well as professional experience as scientists, surgeons, engineers, in-house lawyers and executives, senior regulators at the FDA, HHS and CMS, and enforcement officials at the DOJ.
Named Law 360s Life Sciences Firm of the Year for 2016, the firm currently represents more than 200 pharmaceutical, biotechnology and medical device manufacturers overall, including eight of the top 10 pharmaceutical/biotechnology manufacturers and eight of the top 10 medical device manufacturers. We offer these clients highly specialized experience at every stage of the product life cycle — from emerging growth company counseling on intellectual property, capital-raising transactions, license and corporate partnering agreements, and clinical trials, through FDA approval, manufacturing, marketing, commercial and post-approval regulatory, strategic M&A, and other corporate transactions, to litigation and government and internal investigation matters. Our government affairs lawyers also help our clients in the industry understand and navigate legislative and regulatory developments in Washington, D.C., and in state capitals across the country.
The firm has one of the U.S.’s largest practices representing organizations involved in the delivery of healthcare services and products across all facets of the legal issues they face. We serve the entire spectrum of healthcare institutional providers, practitioners, payors, educators, researchers, inventors, suppliers, investors and manufacturers across the nation.
Our deep bench of litigators marshal a keen understanding of federal and commercial payor reimbursement mechanisms to craft novel and effective case strategies in False Claims Act lawsuits, commercial managed care disputes, government reimbursement suits and civil litigation.
Many of our regulatory lawyers have served in government themselves, experience they leverage across the gamut of compliance reviews and risk assessments, government investigations and enforcement actions, Medicare and Medicaid payment issues, government audits, labor, employment, health and environmental litigation, and in advocacy before the House, Senate, Department of Health & Human Services, Centers for Medicare & Medicaid, Food & Drug Administration and other executive branch agencies.
Our transactional lawyers have been intensely involved in the sweeping evolution of traditional healthcare entity ownership structures and the emergence of new alignments and financing techniques. From boardroom advice to steady guidance through mergers, acquisitions, innovative financings, private equity and other strategic investments, and restructurings, we offer clients a broad team of transactional lawyers who devote all or most of their time to serving our clients in the healthcare sector.